Zobrazeno 1 - 10
of 325
pro vyhledávání: '"Lane JA"'
Autor:
Ito, H, Sakamaki, K, Young, GJ, Blair, PS, Hashim, H, Lane, JA, Kobayashi, K, Clout, M, Chapple, C, Malde, S, Drake, M
Background; Assessment of male lower urinary tract symptoms (LUTS) needs to identify predictors of symptom outcomes, where interventional treatment is planned. Objective; Develop a novel prediction model for prostate surgery outcomes and validate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::99db4afef738336d84e5676f7a28fcac
http://hdl.handle.net/10044/1/105117
http://hdl.handle.net/10044/1/105117
Autor:
Hamdy, FC, Donovan, JL, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Young, GJ, Walsh, EI, Bryant, RJ, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Oxley, J, Williams, NJ, Staffurth, J, Neal, DE
Publikováno v:
Donovan, J L, Lane, J A, Metcalfe, C, Davis, M J, Turner, E L, Martin, R M, Walsh, E I, Peters, TJ & Williams, N J 2023, ' Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer ', New England Journal of Medicine, vol. 388, no. 17, pp. 1547-1558 . https://doi.org/10.1056/NEJMoa2214122
BACKGROUND: Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these men, 1643 were enrolled in a trial to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e71e92ec9ee7e8fc17a27d17b70fd8
https://ora.ox.ac.uk/objects/uuid:b3f24670-b965-4fd7-abb4-5939ae7b7b12
https://ora.ox.ac.uk/objects/uuid:b3f24670-b965-4fd7-abb4-5939ae7b7b12
Autor:
Bryant, RJ, Oxley, J, Young, GJ, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Goepel, JR, Varma, M, Griffiths, DF, Grigor, K, Mayer, N, Warren, AY, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, DJ, F Catto, JW, Neal, DE, Donovan, JL, Hamdy, FC, Protect Study Group, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E
Publikováno v:
Bryant, R J, Oxley, J, Young, G J, Lane, J A, Metcalfe, C, Davis, M, Turner, E L, Martin, R M, Goepel, J R, Varma, M, Griffiths, D F, Grigor, K, Mayer, N, Warren, A Y, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, D J, F Catto, J W, Neal, D E, Donovan, J L, Hamdy, F C, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E & the ProtecT Study Group 2020, ' The ProtecT trial : analysis of the patient cohort, baseline risk stratification and disease progression ', BJU International . https://doi.org/10.1111/bju.14987
OBJECTIVES: The ProtecT (Prostate testing for cancer and Treatment) trial randomised 1,643 men with localised prostate cancer (PCa) to active monitoring, radical prostatectomy or radical radiotherapy. At 10-year median follow-up there were no differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f116adeea8a4a0e19e6d297cd979bd54
https://doi.org/10.1111/bju.14987
https://doi.org/10.1111/bju.14987
Autor:
Watts, EL, Perez-Cornago, A, Appleby, PN, Albanes, D, Ardanaz, E, Black, A, Bueno-De-Mesquita, HB, Chan, JM, Chen, C, Chubb, SAP, Cook, MB, Deschasaux, M, Donovan, JL, English, DR, Flicker, L, Freedman, ND, Galan, P, Giles, GG, Giovannucci, EL, Gunter, MJ, Habel, LA, Häggström, C, Haiman, C, Hamdy, FC, Hercberg, S, Holly, JM, Huang, J, Huang, W-Y, Johansson, M, Kaaks, R, Kubo, T, Lane, JA, Layne, TM, Le Marchand, L, Martin, RM, Metter, EJ, Mikami, K, Milne, RL, Morris, HA, Mucci, LA, Neal, DE, Neuhouser, ML, Oliver, SE, Overvad, K, Ozasa, K, Pala, V, Pernar, CH, Pollak, M, Rowlands, M-A, Schaefer, CA, Schenk, JM, Stattin, P, Tamakoshi, A, Thysell, E, Touvier, M, Trichopoulou, A, Tsilidis, KK, Van Den Eeden, SK, Weinstein, SJ, Wilkens, L, Yeap, BB, Key, TJ, Allen, NE, Travis, RC
Publikováno v:
International journal of cancer, vol 145, iss 12
International Journal of Cancer
International Journal of Cancer, Wiley, 2019, 145 (12), pp.3244-3256. ⟨10.1002/ijc.32276⟩
International Journal of Cancer, 2019, 145 (12), pp.3244-3256. ⟨10.1002/ijc.32276⟩
Watts, E L, Perez-Cornago, A, Appleby, P N, Albanes, D, Ardanaz, E, Black, A, Bueno-de-Mesquita, H B, Chan, J M, Chen, C, Chubb, S A P, Cook, M B, Deschasaux, M, Donovan, J L, English, D R, Flicker, L, Freedman, N D, Galan, P, Giles, G G, Giovannucci, E L, Gunter, M J, Habel, L A, Häggström, C, Haiman, C, Hamdy, F C, Hercberg, S, Holly, J M, Huang, J, Huang, W-Y, Johansson, M, Kaaks, R, Kubo, T, Lane, J A, Layne, T M, Le Marchand, L, Martin, R M, Metter, E J, Mikami, K, Milne, R L, Morris, H A, Mucci, L A, Neal, D E, Neuhouser, M L, Oliver, S E, Overvad, K, Ozasa, K, Pala, V, Pernar, C H, Pollak, M, Rowlands, M-A, Schaefer, C A, Schenk, J M, Stattin, P, Tamakoshi, A, Thysell, E, Touvier, M, Trichopoulou, A, Tsilidis, K K, Van Den Eeden, S K, Weinstein, S J, Wilkens, L, Yeap, B B, Key, T J, Allen, N E & Travis, R C 2019, ' The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies ', International Journal of Cancer, vol. 145, no. 12, pp. 3244-3256 . https://doi.org/10.1002/ijc.32276
Watts, E L, Perez-Cornago, A, Appleby, P N, Albanes, D, Ardanaz, E, Black, A, Bueno-de-Mesquita, H B, Chan, J M, Chen, C, Chubb, S A P, Cook, M B, Deschasaux, M, Donovan, J L, English, D R, Flicker, L, Freedman, N D, Galan, P, Giles, G G, Giovannucci, E L, Gunter, M J, Habel, L A, Häggström, C, Haiman, C, Hamdy, F C, Hercberg, S, Holly, J M, Huang, J, Huang, W Y, Johansson, M, Kaaks, R, Kubo, T, Lane, J A, Layne, T M, Le Marchand, L, Martin, R M, Metter, E J, Mikami, K, Milne, R L, Morris, H A, Mucci, L A, Neal, D E, Neuhouser, M L, Oliver, S E, Overvad, K, Ozasa, K, Pala, V, Pernar, C H, Pollak, M, Rowlands, M A, Schaefer, C A, Schenk, J M, Stattin, P, Tamakoshi, A, Thysell, E, Touvier, M, Trichopoulou, A, Tsilidis, K K, Van Den Eeden, S K, Weinstein, S J, Wilkens, L, Yeap, B B, Key, T J, Allen, N E & Travis, R C 2019, ' The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies ', International Journal of Cancer, vol. 145, no. 12, pp. 3244-3256 . https://doi.org/10.1002/ijc.32276
International Journal of Cancer
International Journal of Cancer, Wiley, 2019, 145 (12), pp.3244-3256. ⟨10.1002/ijc.32276⟩
International Journal of Cancer, 2019, 145 (12), pp.3244-3256. ⟨10.1002/ijc.32276⟩
Watts, E L, Perez-Cornago, A, Appleby, P N, Albanes, D, Ardanaz, E, Black, A, Bueno-de-Mesquita, H B, Chan, J M, Chen, C, Chubb, S A P, Cook, M B, Deschasaux, M, Donovan, J L, English, D R, Flicker, L, Freedman, N D, Galan, P, Giles, G G, Giovannucci, E L, Gunter, M J, Habel, L A, Häggström, C, Haiman, C, Hamdy, F C, Hercberg, S, Holly, J M, Huang, J, Huang, W-Y, Johansson, M, Kaaks, R, Kubo, T, Lane, J A, Layne, T M, Le Marchand, L, Martin, R M, Metter, E J, Mikami, K, Milne, R L, Morris, H A, Mucci, L A, Neal, D E, Neuhouser, M L, Oliver, S E, Overvad, K, Ozasa, K, Pala, V, Pernar, C H, Pollak, M, Rowlands, M-A, Schaefer, C A, Schenk, J M, Stattin, P, Tamakoshi, A, Thysell, E, Touvier, M, Trichopoulou, A, Tsilidis, K K, Van Den Eeden, S K, Weinstein, S J, Wilkens, L, Yeap, B B, Key, T J, Allen, N E & Travis, R C 2019, ' The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies ', International Journal of Cancer, vol. 145, no. 12, pp. 3244-3256 . https://doi.org/10.1002/ijc.32276
Watts, E L, Perez-Cornago, A, Appleby, P N, Albanes, D, Ardanaz, E, Black, A, Bueno-de-Mesquita, H B, Chan, J M, Chen, C, Chubb, S A P, Cook, M B, Deschasaux, M, Donovan, J L, English, D R, Flicker, L, Freedman, N D, Galan, P, Giles, G G, Giovannucci, E L, Gunter, M J, Habel, L A, Häggström, C, Haiman, C, Hamdy, F C, Hercberg, S, Holly, J M, Huang, J, Huang, W Y, Johansson, M, Kaaks, R, Kubo, T, Lane, J A, Layne, T M, Le Marchand, L, Martin, R M, Metter, E J, Mikami, K, Milne, R L, Morris, H A, Mucci, L A, Neal, D E, Neuhouser, M L, Oliver, S E, Overvad, K, Ozasa, K, Pala, V, Pernar, C H, Pollak, M, Rowlands, M A, Schaefer, C A, Schenk, J M, Stattin, P, Tamakoshi, A, Thysell, E, Touvier, M, Trichopoulou, A, Tsilidis, K K, Van Den Eeden, S K, Weinstein, S J, Wilkens, L, Yeap, B B, Key, T J, Allen, N E & Travis, R C 2019, ' The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies ', International Journal of Cancer, vol. 145, no. 12, pp. 3244-3256 . https://doi.org/10.1002/ijc.32276
Insulin‐like growth factors (IGFs) and insulin‐like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0d9295e9e628c08958501abe43889168
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157847
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157847
Autor:
Martin, RM, Donovan, JL, Turner, EL, Metcalfe, C, Young, GJ, Walsh, EI, Lane, JA, Noble, S, Oliver, SE, Evans, S, Sterne, JAC, Holding, P, Ben-Shlomo, Y, Brindle, P, Williams, NJ, Hill, EM, Ng, SY, Toole, J, Tazewell, MK, Hughes, LJ, Davies, CF, Thorn, JC, Down, E, Smith, GD, Neal, DE, Hamdy, FC, Martin, R, Donovan, J, Neal, D, Hamdy, F, Turner, E, Athene Lane, J, Sterne, J, Frankel, S, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rosario, DJ, Rowe, E
IMPORTANCE Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from overdetection and overtreatment. OBJECTIVE To evaluate the effect of a single prostate-specific antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf743f482768e025a43885e8aaf8498
Autor:
Johnston, TJ, Shaw, GL, Lamb, AD, Parashar, D, Greenberg, D, Xiong, T, Edwards, AL, Gnanapragasam, V, Holding, P, Herbert, P, Davis, M, Mizielinsk, E, Lane, JA, Oxley, J, Robinson, M, Mason, M, Staffurth, J, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Prescott, S, Paul, A, Powell, P, Rosario, D, Rowe, E, Donovan, JL, Hamdy, FC, Neal, DE, ProtecT study group
$\textit{Background:}$ Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. $\textit{Objective:}$ To determine outcomes for men diagnosed with advanced PCa following prostate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a51fe9d2bbc6daac12bcec6a5e30bf
Autor:
Donovan, JL, Peters, TJ, Noble, S, Powell, P, Gillatt, D, Oliver, SE, Lane, JA, Neal, DE, Hamdy, FC
BACKGROUND AND OBJECTIVE: Recruitment to randomized trials is often difficult, but few studies have investigated interventions to improve recruitment. In a randomized trial nested within a trial of treatments for localized prostate cancer, we investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::023d99640fe08d85759b5119c6077579
https://ora.ox.ac.uk/objects/uuid:7917774c-be71-48fd-bf40-10a5e2f95ceb
https://ora.ox.ac.uk/objects/uuid:7917774c-be71-48fd-bf40-10a5e2f95ceb